Key result
Porcine circovirus type 2 (PCV2) was detected in 53% of clinical pig samples collected in China from 2018 to 2020, with the PCV2d genotype accounting for 79% of the sequenced isolates.
Why the study?
Rising PCV2 infection rates posed challenges in China, while most commercial vaccines are based on PCV2a rather than the prevalent PCV2b or PCV2d genotypes.
Observational (n=6,827)
Yes
PCV2d is the dominant genotype in China, and PCV2b/PCV2d Cap proteins are promising vaccine candidates providing cross-protection.
High PCV2 prevalence signals urgent prevention needs in Chinese swine; observational data leaves open optimal control strategies.
Porcine circovirus type 2 (PCV2) is one of the smallest known animal viruses and is the main pathogen of PCV-associated diseases (PCVAD). Epidemiological surveillance results have shown that the PCV2 infection rate is on the rise in China, thus, PCV2 disease prevention and control has become a huge challenge for the Chinese swine industry. We collected clinical samples from multiple different provinces in China from 2018 to 2020 and found that the positive rate of PCV2 was 53% (3619/6872), identity between the cloned 62 ORF2 genes was 84.4–100% and identity between the cloned 62 ORF2 sequences and reference sequence was 72.9–99.8%. Genetic evolution analysis found that PCV2d accounted for 79% (49/62 samples), PCV2a for 12.9% (8/62 samples), PCV2b for 8% (5/62 samples), and PCV2c and PCV2e genotypes were not found. However, most commercial PCV2 subunit vaccines are based on the PCV2a genotype, and there are very few vaccines based on PCV2b or PCV2d. Therefore, the homologous and heterologous protection ability of PCV2b and PCV2d Cap proteins based on the baculovirus against the PCV2b and PCV2d infections was evaluated, which is expected to design and develop excellent PCV2 protein vaccine candidates. This study found that both PCV2b and PCV2d Cap proteins can increase the level of humoral immunity and cellular immune response in mice. Importantly, both PCV2b and PCV2d cap proteins can provide homologous and heterologous protection against the PCV2b and PCV2d viruses. Overall, this study provides a reference for the prevention and control of PCVAD in mainland China and the development of PCV2 vaccines.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2021) conducted an observational in Porcine Circovirus Type 2 (PCV2) (n=6,827). Porcine Circovirus Type 2 (PCV2) exposure vs. Unexposed/Negative samples was evaluated on PCV2 positive rate. Porcine circovirus type 2 (PCV2) was detected in 53% of clinical pig samples collected in China from 2018 to 2020, with the PCV2d genotype accounting for 79% of the sequenced isolates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: